Distinguishing the glycan isomers 2,3-sialyllactose and 2,6-sialyllactose by voltammetry after modification with osmium(VI) complexes
-
Add time:08/31/2019 Source:sciencedirect.com
Altered glycosylation is a universal feature of cancer cells and certain glycans are well-known markers of tumor progression. In this work we studied two glycan isomers, 2,3-sialyllactose (3-SL) and 2,6-sialyllactose (6-SL), frequently appearing in glycoproteins connected with cancer. A combination of square wave voltammetry and glycan modification with osmium(VI) N,N,N′,N′-tetramethylethylenediamine (Os(VI)tem) allowed to distinguish between these regioisomers, since the 6-SL molecule can bind three Os(VI), while the 3-SL only two Os(VI) moieties, as experiments using capillary electrophoresis, inductively coupled plasma mass spectrometry and thin layer chromatography showed. A similar pattern of Os(VI)-modification was found for isomers of sialyl-N-acetyllactosamine and sialylgalactose. Covalent adducts of Os(VI)tem with glycans yielded three reduction voltammetric peaks. The ratio of peak I/peak II heights depends on the content of individual regioisomer in the sample. Our proposed approach allows the determination of isomer percentage representation in the mixture after one voltammogram recording. These results show a new appropriate method for the discrimination of glycan isomers containing terminal sialic acid important for distinguishing between cancerous and non-cancerous origin of biomarkers.
We also recommend Trading Suppliers and Manufacturers of POTASSIUM OSMATE(VI) DIHYDRATE (cas 19718-36-6). Pls Click Website Link as below: cas 19718-36-6 suppliers
Prev:Studies on palladium-catalyzed enantioselective cyclization of 3,4-allenylic hydrazines with organic halides
Next:Distinguishing glycan isomers by voltammetry. Modification of 2,3-sialyllactose and 2,6-sialyllactose by osmium(VI) complexes) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short communicationOs(VI)bipy-based electrochemical assay for detection of specific microRNAs as potential cancer biomarkers09/06/2019
- Facile end-labeling of RNA with electroactive Os(VI) complexes09/05/2019
- Synthesis and pharmacological evaluation of potential metabolites of the potassium-competitive acid blocker BYK 40587909/04/2019
- Voltammetric determination of Os(VI)-modified oligosaccharides at nanomolar level09/03/2019
- Total α1-acid glycoprotein determination in serum samples using disposable screen-printed electrodes and osmium (VI) as electrochemical tag09/02/2019
- Distinguishing glycan isomers by voltammetry. Modification of 2,3-sialyllactose and 2,6-sialyllactose by osmium(VI) complexes09/01/2019
-
Health and Chemical more >
-
Related Products
- Potassium (2S,3S)-3-(ethoxycarbonyl)oxirane-2-carboxylate
- Potassium (4-formylphenyl)trifluoroborate
- Potassium (bromomethyl)trifluoroborate
- Potassium (R)-((3-ethoxy-1-methyl-3-oxoprop-1-enyl)amino)(4-hydroxyphenyl)acetate
- Potassium (R)-(4-hydroxyphenyl)((3-methoxy-1-methyl-3-oxoprop-1-enyl)amino)acetate
- Potassium (R)-[(3-ethoxy-1-methyl-3-oxoprop-1-enyl)amino]phenylacetate
- Potassium [(cyanomethyl)thio]acetate
- Potassium 1,2,3,6-tetrahydro-5-nitro-2,6-dioxopyrimidine-4-carboxylate
- Potassium 2,2-dimethyl-1,3-dioxolane-4-carboxylate
- Potassium 2,3,3-trimethyl-3H-indole-5-sulfonate


